features: Multiple Sclerosis and Related Disorders

BTK inhibitors: From the treatment of cancer to multiple sclerosis

The role of BTK inhibitors (BTKis) in cancer treatment has been well-established, but what prospects do they have in treating…

Epstein-Barr virus may be the predominant trigger of multiple sclerosis

A record-breaking study into the relationship between Epstein-Barr virus (EBV) infection and multiple sclerosis (MS) onset has revealed a 32-fold…

The present and future of biomarkers in MS

Biomarker research was a major talking point at ECTRIMS 2021. Discover the latest developments discussed at the meeting, from moving…

COVID-19 vaccination in patients with multiple sclerosis

Real-world data sets were presented at 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS),…

Highlights from ACTRIMS Forum 2021

Masitinib: the first drug slowing progressive MS pathology

Multiple sclerosis (MS) is a long-life condition that affects the brain and spinal cord resulting in impaired vision, limb movement,…